Amyotrophic Lateral Sclerosis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for amyotrophic lateral sclerosis. 15 active patents protecting 3 drugs from 3+ originators. First major cliff: 2029. Daily refresh.

3
Approved drugs
15
Active US patents
63/100
Avg vulnerability
$200M
Annual revenue covered

Originators in Amyotrophic Lateral Sclerosis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Kk Bcj-94 11 patents Biogen Ma 3 patents Covis 1 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating amyotrophic lateral sclerosis. Each bar = one year. Y-axis scaled to peak year (6 patents).

1
29
3
35
6
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Radicava
EDARAVONE
 Kk Bcj-94 11 64 — 2039-11-01
Qalsody
TOFERSEN
 Biogen Ma 3 51 $200M 2035-04-01
Rilutek
RILUZOLE
 Covis 1 75 — 2029-03-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8765150 Rilutek method of use 75 2029-03-12
12478611 Radicava method of use 75 2041-11-12
12569469 Radicava method of use 75 2041-11-12
12527769 Radicava method of use 75 2041-11-12
12194025 Radicava method of use 75 2041-11-12
12310946 Radicava method of use 75 2041-11-12
10968453 Qalsody method of use 70 2035-04-01
10669546 Qalsody method of use 70 2035-04-01
11478450 Radicava method of use 70 2039-11-01
11957660 Radicava formulation 55 2039-11-01

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10385341 Qalsody composition of matter 12 2035-04-01
11826352 Radicava formulation 50 2039-11-01
11241416 Radicava formulation 50 2039-11-01
10987341 Radicava formulation 50 2039-11-01
12285409 Radicava formulation 55 2039-11-01
11957660 Radicava formulation 55 2039-11-01
11478450 Radicava method of use 70 2039-11-01
10669546 Qalsody method of use 70 2035-04-01
10968453 Qalsody method of use 70 2035-04-01
12478611 Radicava method of use 75 2041-11-12

Related